[1] Christakou C,Diamanti-Kandarakis E. Polycystic ovary syndrome-phenotypes and diagnosis[J]. Scandinavian J Clin Laboratory Invest,2014,74 (Suppl244):18
[2] Otta C F,Cuneo M F D,Mereshian P S D. Polycystic ovary syndrome:physiopathology review[J]. Rev Fac Cien Med Univ Nac Cordoba,2013,70(1):27
[3] 张春仁,宋金龙,李娟. 多囊卵巢综合征与相关微小RNA的研究进展[J]. 国际生殖健康/计划生育杂志,2016,35(5):418
[4] Sang Q,Yao Z,Wang H,et al. Identification of microRNAs in human follicular fluid:characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo[J]. J Clin Endocrinol Metab,2013,98(7):3068
[5] 谢军,韩造木,尹琬凌. 微RNA-27a介导3T3-L1脂肪细胞胰岛素抵抗的作用机制[J]. 安徽医药,2019,23(12):2378
[6] Wang M,Liu M,Sun J,et al. MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model[J]. Reprod Biol,2017,17(4):295
[7] Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Repord,2004,19(1):41
[8] Guastella E,Longo R A,Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes[J]. Fertil Steril,2010,94(6):2197
[9] Long W,Zhao C,Ji C,et al. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers[J]. Cellular Physiol Biochem,2014,33(5):1304
[10] 王洁,王倩,崔趁趁,等. 多囊卵巢综合征患者血清外泌体中差异表达microRNAs及其功能分析[J]. 山东医药,2019,59(6):35
[11] Wang Y,Xu S,Wang Y,et al. Identification and potential value of candidate microRNAs in granulosa cells of polycystic ovary syndrome[J]. Technol Health Care,2019,27(6):579
[12] Feng L,Shen F,Zhou J,et al. Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer[J]. Biosci Rep,2020,40(4):BSR20192457
[13] Zhou L,Liang X,Zhang L,et al. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2[J]. Oncotarget,2016,7(32):51943
[14] Salah Z,Arafeh R,Maximov V,et al. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells[J]. Oncotarget,2015,6(7):4920
[15] 聂明月. miR-23a和miR-27a在卵巢中的生理与病理作用[J].国际生殖健康/计划生育杂志,2014,33(5):367
[16] Nunez Lopez Y O,Garufi G,Seyhan A A. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes[J]. Mol Biosyst,2016,13(1):106
[17] Karolina D S,Tavintharan S,Armugam A,et al. Circulating miRNA profiles in patients with metabolic syndrome[J]. J Clin Endocrinol Metab,2012,97(12):E2271
[18] 谢军,蔡克银. MiRNA-27a对3T3-L1细胞胰岛素抵抗的作用及机制[J]. 华南国防医学杂志,2014,28(2):97
[19] Krentowska A,Ponikwicka-Tyszko D,Lebkowska A,et al.The association of serum miR-27a and miR-320 level with glucose metabolism and insulin sensitivity in young women with polycystic ovary syndrome// 22nd European Congress of Endocrinology[C]. BioScientifica,2020(70):AEP831
[20] Fan Y,Yu Y,Feng L,et al. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity[J]. Exp Cell Res,2017,355(2):105
[21] Yu Y,Du H,Wei S,et al. Adipocyte-derived exosomal miR-27a induces insulin resistance in skeletal muscle through repression of PPARγ[J]. Theranostics,2018,8(8):2171
[22] 许伟伟,许昌,谭慧芳,等. miR-21、miR-27a、miR-27b的表达水平对多囊卵巢综合征患者肥胖及代谢紊乱的影响[J]. 临床检验杂志,2017,35(3):193
[23] Wang M,Sun J,Xu B,et al. Functional characterization of microRNA-27a-3p expression in human polycystic ovary syndrome[J]. Endocrinology,2018,159(1):297
[1]李 江,王 刚.性激素结合球蛋白在多囊卵巢综合征患者中的变化及与其他指标的关系[J].天津医科大学学报,2016,22(04):325.
LI Jiang,WANG Gang.Changes of SHBG in patients with polycystic ovary syndrome and their relationship with other indicators[J].Journal of Tianjin Medical University,2016,22(02):325.
[2]李英,张学军.miR-93在多囊卵巢综合征患者血清中的表达及临床意义[J].天津医科大学学报,2018,24(03):209.
LI Ying,ZHANG Xue-jun.Expression and clinical significance of miR-93 in the serum of patients with polycystic ovary syndrome[J].Journal of Tianjin Medical University,2018,24(02):209.
[3]张 悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(06):469.
ZHANG Yue,GUAN Xu-wen,WANG Jing-ya,et al.Influence of miR-27a on apoptosis of gastric cancer cells in vitro[J].Journal of Tianjin Medical University,2018,24(02):469.
[4]刘 娇,罗海宁,韩 莹,等.比较GnRH激动剂长方案与GnRH拮抗剂方案对LH/FSH比值大于等于2的多囊卵巢综合征患者临床结局影响[J].天津医科大学学报,2019,25(04):382.
LIU Jiao,LUO Hai-ning,HAN Ying,et al.Effects of different GnRH-analogue on polycystic ovarian syndrome with LH/FSH ratioof 2 or higher[J].Journal of Tianjin Medical University,2019,25(02):382.
[5]邹怡欣,时雨杰综 述,刘 煜,等.多囊卵巢综合征与生物钟的研究进展[J].天津医科大学学报,2020,26(01):91.
[6]董蕾,史天云.多囊卵巢综合征外周血中miR-132和SMAD4的表达对颗粒细胞增殖和凋亡的影响[J].天津医科大学学报,2022,28(05):525.
DONG Lei,SHI Tian-yun.Effects of miR-132 and SMAD4 expression in peripheral blood of polycystic ovary syndrome on the proliferation and apoptosis of granulosa cells[J].Journal of Tianjin Medical University,2022,28(02):525.
[7]孙奎奎,杨微微,王文靖,等.多囊卵巢综合征关键基因的筛选及其与疾病进展和预后的相关性分析[J].天津医科大学学报,2023,29(06):609.
SUN Kui-kui,YANG Wei-wei,WANG Wen-jing,et al.Screening of key genes in polycystic ovary syndrome and analysis of their correlation with disease progression and prognosis[J].Journal of Tianjin Medical University,2023,29(02):609.